Urteste plans clinical trials for pancreatic cancer test Panuri in Europe and US

From GlobeNewswire: 2025-03-27 11:21:00

Urteste S.A. plans to begin clinical trials for its pancreatic cancer test, Panuri, in Europe in Q3 2025. The study will involve 550 patients in Poland and selected EU countries, marking a significant step towards certification in Europe. Additionally, the company is preparing for U.S. trials and will finalize details with the FDA in mid-2025. Urteste specializes in cancer detection through unique urine sample analysis and has 12 prototype diagnostic tests for various cancers. Their technology measures enzyme activity in urine samples, potentially indicating the presence of cancer. For more information, visit www.urteste.eu/en/home/.



Read more at GlobeNewswire: Urteste plans to start clinical trials for its pancreatic